DNA testing services are listed below by and by . Click on a test for a brief description with a link to a detailed assay summary which includes specimen requirements, .
For the current price list, please email us at email@example.com
with your name, title and institution. Please review the , , and pages. If you have questions, please . If you are a patient, please see our . Some of our services are described in which are available for download or by mail.
Multiple and complementary tests are available for comprehensive diagnostic testing. For most genes, sequence analysis covers the entire coding region and associated splice junctions. For many genes, deletion/duplication analysis is also available.
(Targeted analysis of ~2800 COSMIC mutations of oncogenes and tumor suppressor genes frequently mutated in human cancers)
(Fusion analysis of 7 genes commonly rearranged in solid tumors (ALK, RET, ROS1, PPARG, NTRK1, NTRK3, FGFR3))
(Analysis for ~2800 COSMIC mutations in 48 oncogenic and tumor suppressor genes frequently mutated in human cancers and fusions involving ALK, RET, ROS1, PPARG, NTRK1, NTRK3, FGFR3.)
(Targeted analysis for ~1700 hotspot mutations within genes mutated in lung cancers (AKT1, ALK, BRAF, EGFR, ERBB2, KRAS, MET, NRAS, PIK3CA, PTEN, STK11, TP53))
(Targeted analysis for ~425 hotspot mutations within genes mutated in melanomas (BRAF, CTNNB1, GNA11, GNAQ, KIT, NRAS, KRAS, HRAS))
(Targeted analysis for ~469 hotspot mutations within genes frequently mutated in colorectal cancers (AKT1, BRAF, KRAS, NRAS, PIK3CA, PTEN, SMAD4, SRC))
(Targeted analysis for 124 cancer hotspot mutations in the KRAS, NRAS and HRAS genes by next generation sequencing.)
(MLH1, MSH2, MSH6, PMS2: Seq+MLPA, EPCAM: MLPA)
(PTEN, STK11, CHEK2, TP53, PALB2, ATM and CDH1, full gene sequencing)
(HNPCC Immunohistochemistry- MLH1, MSH2, MSH6, PMS2)
(APC and MUTYH: Full gene sequencing, APC: MLPA)